Each citation lists study type, research model, year, and a candid summary of limitations. We separate human evidence from preclinical and mechanistic findings.
Established human evidence·Human RCT · Phase 2·New England Journal of Medicine · 2023
Triple-Hormone-Receptor Agonist Retatrutide for Obesity
Retatrutide was evaluated in adults with obesity in a randomized, placebo-controlled trial reporting dose-dependent body-weight changes and gastrointestinal adverse events.
Limitations · Investigational compound. Trial findings do not establish the safety, quality, or equivalence of independently manufactured research material.
DOIPubMedClinicalTrials.govView Citation
Predominantly preclinical·Animal · In vivo·Journal of Orthopaedic Research · 2019
BPC-157 in Models of Tendon and Ligament Healing
Rodent injury models reported accelerated tendon-to-bone healing markers following systemic and local administration of BPC-157.
Limitations · No controlled human trials. Findings have not been replicated in clinical settings.
DOIPubMedClinicalTrials.govView Citation
Mechanistic or speculative·In vitro·Biological Trace Element Research · 2017
GHK-Cu Modulation of Cellular Repair Genes
Transcriptional analysis suggested GHK-Cu modulates expression of genes associated with tissue remodeling and antioxidant response in cultured cells.
Limitations · Cell-culture data only. Translational relevance to in vivo or human outcomes is undetermined.
DOIPubMedClinicalTrials.govView Citation
Limited human evidence·Animal · Behavioral·Neuroscience Letters · 2015
Selank: Anxiolytic-Like Effects in Rodent Models
Rodent assays observed reduced anxiety-like behavior with intranasal administration. Small early human studies reported tolerability signals.
Limitations · Sparse controlled human data. Effects in humans remain under-characterized.
DOIPubMedClinicalTrials.govView Citation
Established human evidence·Human RCT · Phase 3·The Lancet · 2021
Tirzepatide for the Treatment of Type 2 Diabetes (SURPASS Program)
Phase 3 trials demonstrated reductions in HbA1c and body weight versus comparators across multiple patient populations.
Limitations · Findings reflect the regulated pharmaceutical product. Independently manufactured research material is not equivalent.
DOIPubMedClinicalTrials.govView Citation
Predominantly preclinical·In vitro·Bulletin of Experimental Biology and Medicine · 2003
Epitalon and Telomerase Activity in Cultured Cells
Observations of telomerase activity and senescence markers in cultured cells following exposure to the synthetic tetrapeptide Epitalon.
Limitations · No replication in modern controlled human trials. Mechanistic claims remain speculative.